I believe the Chinese need country of origin approval - TGA - so application can be made there. FDA is frustrating; they haven't begun trials for adults yet. Anyhow, no negative thoughts today!
- Forums
- ASX - By Stock
- RAP
- Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark
Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark, page-25
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)